Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Healthy × Adalimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Uveal Melanoma 1 Thyroid Carcinoma, Anaplastic 1 Melanoma 1 Healthy Adult Male 1 Healthy 1

Interventions

pimodivir 1 Sunitinib 1 Rosuvastatin Calcium 1 Midazolam 1 Cyclosporine 1 Adalimumab 1 (2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02912247 2019-03-07

Comparative Clinical Trial to Evaluate Bioequivalency and Safety of Monoclonal Antibody Injection and Adalimumab in Chinese Healthy Volunteers

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Completed

Healthy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡